Verified Service Provider in Guinea-Bissau
Genomics Core Facilities in Guinea-Bissau
Engineering Excellence & Technical Support
Genomics Core Facilities solutions for Research & Discovery (R&D). High-standard technical execution following OEM protocols and local regulatory frameworks.
High-Throughput Sequencing Services
Empowering genomic research in Guinea-Bissau with cutting-edge next-generation sequencing platforms for whole-genome, exome, and targeted sequencing. Accelerate discovery in infectious diseases, agricultural genomics, and human health.
Advanced Bioinformatics Support
Comprehensive bioinformatics pipeline development and analysis services. From raw data processing to complex variant calling and annotation, we provide expert support to extract meaningful biological insights from genomic datasets.
Capacity Building and Training
Dedicated to fostering local expertise in genomics. We offer hands-on training workshops and collaborative project support, equipping researchers and technicians with the skills to conduct independent genomic studies.
What Is Genomics Core Facilities In Guinea-bissau?
Genomics Core Facilities in Guinea-Bissau represent specialized service units that provide access to advanced genomic technologies, expertise, and instrumentation for research and diagnostic applications. These facilities are instrumental in enabling a wide range of biological investigations by offering standardized, high-throughput, and cost-effective genomic services. Their primary function is to democratize access to complex genomic analyses, thereby supporting scientific advancement and public health initiatives within the country.
| User Group | Needs Addressed | Typical Use Cases |
|---|---|---|
| Academic Researchers (Universities, Research Institutes) | Access to cutting-edge genomic technologies and analytical expertise for hypothesis-driven research. Cost-effective outsourcing of complex genomic experiments. | Disease gene discovery (infectious diseases, non-communicable diseases), understanding genetic diversity, population genetics studies, agricultural genomics for crop/livestock improvement, environmental DNA (eDNA) analysis for biodiversity monitoring. |
| Public Health Laboratories | Rapid and accurate identification of pathogens, antimicrobial resistance profiling, outbreak surveillance, and diagnostic assay development. | Epidemiological surveillance of infectious diseases (e.g., malaria, tuberculosis, COVID-19), tracking the evolution of pathogens, monitoring drug resistance patterns, identifying novel infectious agents. |
| Clinical Diagnostic Laboratories | Development and implementation of genetic tests for inherited diseases, cancer diagnostics, and pharmacogenomics. | Prenatal screening, diagnosis of rare genetic disorders, tumor profiling for targeted therapy selection, personalized medicine approaches. |
| Government Agencies (Ministry of Health, Ministry of Agriculture, Environmental Agencies) | Data-driven policy making, public health program evaluation, biosecurity measures, and natural resource management. | Monitoring of zoonotic disease risks, assessment of agricultural pest resistance, environmental impact assessments, conservation genetics of endangered species. |
| Biotechnology and Pharmaceutical Companies (if present) | Drug discovery and development, target identification, and validation. | Genomic screening for drug targets, characterization of disease models, development of companion diagnostics. |
Services Offered by Genomics Core Facilities
- DNA/RNA extraction and quality control
- Next-Generation Sequencing (NGS) library preparation (e.g., whole genome, exome, transcriptome, amplicon sequencing)
- NGS data acquisition (sequencing runs on platforms like Illumina, Oxford Nanopore)
- Bioinformatic analysis pipelines (e.g., variant calling, gene expression analysis, metagenomics)
- Genotyping services (e.g., SNP genotyping, microsatellite analysis)
- Epigenomic analysis (e.g., ChIP-seq, ATAC-seq)
- Consultation and training on experimental design and data interpretation
Who Needs Genomics Core Facilities In Guinea-bissau?
Genomics core facilities are essential for advancing research, diagnostics, and public health initiatives. In Guinea-Bissau, these facilities can serve a diverse range of customers, from academic researchers to healthcare professionals and government agencies, playing a crucial role in tackling health challenges and fostering scientific development.
| Customer Segment | Key Departments/Units | Primary Needs/Applications |
|---|---|---|
| Academic and Research Institutions (e.g., Universidade da Integração Internacional da Lusofonia Afro-Brasileira - UNILAB Guinea-Bissau campus, future research centers) | Department of Biology, Department of Health Sciences, Research Labs focusing on infectious diseases, tropical medicine, genetics, epidemiology | Gene sequencing for pathogen identification and tracking (malaria, HIV, TB, emerging infectious diseases), population genetics studies, genetic basis of local diseases, biodiversity research, training of future scientists. |
| Healthcare Providers and Public Health Laboratories (e.g., National Public Health Laboratory, University Hospital of Amura, regional hospitals) | Microbiology Units, Virology Units, Parasitology Units, Clinical Genetics Services (future development), Disease Surveillance Units | Rapid and accurate pathogen identification and drug resistance profiling, outbreak investigations, diagnostic testing for genetic disorders (e.g., sickle cell anemia), development of targeted therapies, public health surveillance. |
| Government Ministries and Agencies (e.g., Ministry of Public Health, Ministry of Higher Education and Scientific Research, Ministry of Agriculture) | National Disease Control Programs, Epidemiology Units, Research & Development Divisions, Food Safety Agencies, Veterinary Services | Epidemiological surveillance, monitoring disease trends, informing public health policy, drug resistance monitoring, research into zoonotic diseases, agricultural pest identification and management, food security initiatives. |
| Non-Governmental Organizations (NGOs) involved in health and development (e.g., Médecins Sans Frontières (MSF), World Health Organization (WHO) country office, other international health organizations) | Field Research Teams, Program Implementation Units, Disease Outbreak Response Teams | Support for field-based research, rapid diagnostics in resource-limited settings, impact assessment of interventions, understanding disease dynamics in local populations, capacity building for local partners. |
| Agricultural Sector Researchers (e.g., national agricultural research institutes, projects focused on food security) | Plant Pathology Departments, Animal Health Units, Agronomy Research Labs | Identification of plant and animal diseases, understanding genetic diversity of local crops and livestock for improved breeding, pest and disease resistance studies, contributing to food security and economic development. |
Target Customers and Departments for Genomics Core Facilities in Guinea-Bissau
- Academic and Research Institutions
- Healthcare Providers and Public Health Laboratories
- Government Ministries and Agencies
- Non-Governmental Organizations (NGOs)
- Agricultural Sector Researchers
Genomics Core Facilities Process In Guinea-bissau
This document outlines the typical workflow for accessing services at Genomics Core Facilities in Guinea-Bissau, from initial inquiry to the completion of genomic analyses. It emphasizes a structured approach to ensure efficient project management and accurate delivery of results.
| Phase | Key Activities | Responsible Party | Deliverables/Outcomes |
|---|---|---|---|
| Inquiry & Consultation | Initial contact, needs assessment, service identification, feasibility check. | Researcher & Core Facility Staff | Understanding of project scope, preliminary service recommendations. |
| Project Proposal & Planning | Formal request, detailed design, protocol finalization, quote, agreement. | Researcher & Core Facility Staff | Signed service agreement, detailed project plan, formal quote. |
| Sample Submission & QC | Sample collection, submission, incoming QC, logging, notification. | Researcher & Core Facility Staff | Accepted, logged, and quality-checked samples; notification of status. |
| Execution (Library Prep & Sequencing/Genotyping) | Library preparation, library QC, sequencing/genotyping run, data generation. | Core Facility Staff | Raw sequencing reads or genotype data. |
| Data Analysis & Interpretation | Raw data QC, bioinformatics pipeline processing, data QA, interpretation. | Core Facility Staff (potentially with Researcher collaboration) | Processed data files, initial analysis results. |
| Reporting & Data Delivery | Report generation, data file delivery, archiving. | Core Facility Staff | Comprehensive data report, final data files. |
| Follow-up & Support | Post-project discussion, troubleshooting, publication support. | Core Facility Staff & Researcher | Clarified results, potential future collaborations, successful publications. |
Genomics Core Facility Workflow in Guinea-Bissau
- 1. Inquiry and Consultation:
- Initial Contact: Researchers (e.g., from universities, research institutes, hospitals, or NGOs) initiate contact with the Genomics Core Facility via email, phone, or in-person visit.
- Needs Assessment: A preliminary discussion is held to understand the researcher's project goals, experimental design, specific genomic questions, and the type of data required (e.g., sequencing, genotyping, gene expression analysis).
- Service Identification: Based on the needs assessment, the core facility staff identifies the most suitable services and methodologies offered.
- Preliminary Quotation/Feasibility Assessment: A rough estimate of costs and an assessment of the project's feasibility are provided, along with information on turnaround times.
- Guidance on Sample Requirements: Advice is given on the type, quantity, quality, and preservation methods for biological samples required for the chosen service.
- 2. Project Proposal and Planning:
- Formal Request: The researcher submits a formal service request or project proposal detailing the experimental objectives, sample information, desired analyses, and budget.
- Detailed Consultation & Experimental Design: In-depth discussions occur with core facility scientists to finalize the experimental design, including specific assays, library preparation methods, sequencing platforms, and bioinformatics pipelines.
- Protocol Development/Adaptation: If necessary, specific protocols are developed or adapted to meet the unique requirements of the project.
- Formal Quote and Service Agreement: A detailed quotation outlining all costs, services, deliverables, and timelines is provided. A service agreement or memorandum of understanding (MOU) is signed, formalizing the project.
- 3. Sample Submission and Quality Control:
- Sample Collection and Preparation: Researchers collect and prepare biological samples according to the agreed-upon protocols and guidelines provided by the core facility.
- Sample Shipment/Delivery: Samples are safely transported to the core facility, adhering to any specific shipping or handling requirements.
- Incoming Sample QC: Upon arrival, samples undergo rigorous quality control checks (e.g., DNA/RNA integrity, concentration assessment, purity) using methods like gel electrophoresis, spectrophotometry, or Qubit assays.
- Sample Log-in and Barcoding: Samples are systematically logged into the core facility's inventory system and assigned unique identifiers and barcodes for tracking.
- Notification of Acceptance/Rejection: The researcher is informed about the acceptance or rejection of samples based on QC results, with reasons for rejection provided if applicable.
- 4. Library Preparation and Sequencing/Genotyping (Execution Phase):
- Library Preparation: For sequencing projects, DNA or RNA is extracted (if not provided), fragmented, and converted into sequencing libraries using specific kits and protocols (e.g., Illumina, PacBio). For genotyping, appropriate arrays or target enrichment methods are used.
- Library QC: Prepared libraries undergo quality control to assess concentration, fragment size distribution, and purity.
- Sequencing or Genotyping Run: Libraries are loaded onto the chosen sequencing platform (e.g., Illumina MiSeq/NovaSeq, Oxford Nanopore) or processed for genotyping (e.g., array hybridization).
- Data Generation: Raw data is generated by the instrument.
- 5. Data Analysis and Interpretation:
- Raw Data QC: Initial assessment of raw sequencing reads or genotype data for quality metrics (e.g., read length, quality scores, call rates).
- Bioinformatics Pipeline: Raw data is processed through established bioinformatics pipelines for tasks such as: alignment to a reference genome, variant calling, gene expression quantification, assembly, or statistical analysis.
- Data Processing and Quality Assurance: Intermediate and final data products are subjected to rigorous quality checks.
- Data Interpretation (Optional/Collaborative): The core facility may provide basic data interpretation, or collaborate with the researcher for in-depth biological interpretation and manuscript preparation.
- 6. Reporting and Data Delivery:
- Data Report Generation: Comprehensive reports are generated, summarizing experimental procedures, quality control metrics, raw data, processed data, and key findings.
- Data Delivery: Final data files (e.g., FASTQ, BAM, VCF, counts matrices, summary statistics) and reports are delivered to the researcher via secure file transfer protocols (e.g., FTP, cloud storage).
- Archiving: Data and samples are archived according to the core facility's policies and any regulatory requirements.
- 7. Follow-up and Support:
- Post-Project Consultation: Discussions about the results, potential next steps, or troubleshooting.
- Troubleshooting and Re-analysis (if needed): Addressing any issues or questions arising from the data.
- Publication Support: Assistance with methodology descriptions for publications.
Genomics Core Facilities Cost In Guinea-bissau
Genomics core facilities in Guinea-Bissau are a nascent but developing area, and as such, detailed public pricing lists are not readily available. The cost of genomics services is heavily influenced by a multitude of factors, often making exact figures difficult to ascertain without direct consultation with the specific facility or researcher. Key pricing factors include the type of genomic assay (e.g., whole-genome sequencing, exome sequencing, targeted sequencing, genotyping, epigenomics), the organism being studied (e.g., human, microbial, plant, insect), the required read depth and coverage, the technology platform employed (e.g., Illumina, PacBio, Oxford Nanopore), the scale of the project (number of samples), and the level of data analysis and interpretation required. Furthermore, the cost of reagents, consumables, instrument maintenance, personnel expertise, and overheads contribute significantly. Due to the limited number of established core facilities and the reliance on imported materials and specialized equipment, costs can be perceived as high relative to local income levels. Prices are typically quoted in Guinea-Bissau's national currency, the West African CFA franc (XOF). While specific price ranges are elusive, it's reasonable to expect that even basic sequencing services could range from several hundred thousand to over a million XOF per sample, with more complex analyses and larger projects incurring substantially higher costs. Collaboration with international research institutions or the availability of grant funding often plays a crucial role in enabling genomic research in Guinea-Bissau, offsetting some of these direct costs.
| Service Type (Illustrative) | Estimated Cost Range (XOF per sample) | Notes |
|---|---|---|
| Basic DNA Extraction | 5,000 - 20,000 | Varies based on tissue type and extraction method. |
| PCR-based Genotyping (e.g., SNP genotyping) | 50,000 - 150,000 | Dependent on the number of markers and throughput. |
| Targeted Gene Sequencing (e.g., Sanger sequencing of a few genes) | 100,000 - 300,000 | Includes sequencing and basic analysis. High variability. |
| Next-Generation Sequencing (NGS) - Targeted Panel Sequencing | 300,000 - 1,000,000+ | Depends on panel size, coverage, and platform. Data analysis adds cost. |
| Next-Generation Sequencing (NGS) - Exome Sequencing | 750,000 - 2,500,000+ | Higher cost due to larger target region and coverage requirements. Bioinformatics is crucial. |
| Next-Generation Sequencing (NGS) - Whole Genome Sequencing (WGS) | 1,500,000 - 5,000,000+ | Most comprehensive, thus most expensive. Significant bioinformatics investment. |
Key Factors Influencing Genomics Core Facility Costs in Guinea-Bissau
- Type of genomic assay (e.g., WGS, exome sequencing, targeted panels, genotyping)
- Organism of study (human, microbial, plant, insect, etc.)
- Required sequencing depth and coverage
- Technology platform used (e.g., Illumina, PacBio, Oxford Nanopore)
- Project scale (number of samples)
- Level of data analysis and bioinformatics support
- Cost of imported reagents and consumables
- Instrument purchase, maintenance, and operational costs
- Personnel expertise and salaries
- Facility overheads and administrative costs
- Customization and special requests
Affordable Genomics Core Facilities Options
Establishing or accessing genomics capabilities is crucial for research and development, but can be a significant investment. Fortunately, there are several affordable options and cost-saving strategies available, often centered around leveraging core facilities. Core facilities offer shared access to expensive equipment and specialized expertise, making advanced genomics accessible to a wider range of institutions and researchers.
| Strategy/Bundle | Description | Cost-Saving Benefit | Ideal For |
|---|---|---|---|
| Core Facility Membership | Annual fee or per-use charges for access to equipment, reagents, and trained personnel. | Economies of scale, reduced capital expenditure, access to latest technology. | Institutions and researchers without dedicated genomics infrastructure or with fluctuating needs. |
| Project-Based Outsourcing | Engaging a core facility for specific genomics services for a defined project. | Pay-as-you-go model, avoids long-term infrastructure investment, access to specialized expertise. | Researchers with specific project needs, limited internal expertise, or seeking to validate a new technology. |
| Consortia & Collaborations | Pooling resources with other institutions to jointly purchase and manage shared genomics platforms. | Significantly reduced individual capital investment, shared operational costs, access to higher-end instrumentation. | Multiple institutions with overlapping research interests and a commitment to shared resource management. |
| Training & 'Do-It-Yourself' Access | Core facilities offering training sessions and supervised access to equipment for researchers to perform basic procedures. | Reduces reliance on core facility staff time for routine tasks, builds internal capacity, lowers per-sample costs for trained individuals. | Researchers who need to perform repetitive or standard genomics assays. |
| Data Analysis Packages | Bundled services including raw data processing, quality control, and basic bioinformatic analysis. | Cost-effective access to bioinformatics expertise, standardized analysis pipelines, faster turnaround times. | Researchers who lack in-house bioinformatics support or require standardized analyses. |
Key Value Bundles and Cost-Saving Strategies for Affordable Genomics Core Facilities
- Consortium and Shared Resources: Joining or forming research consortia allows institutions to collectively invest in and share the costs of high-throughput sequencing platforms, mass spectrometers, and other specialized equipment, reducing individual financial burdens.
- Service-Based Core Facilities: Outsourcing specific genomics services (e.g., library preparation, sequencing, data analysis) to dedicated core facilities, rather than building in-house capabilities, can be more cost-effective, especially for projects with fluctuating needs.
- Tiered Service Levels: Many core facilities offer different service tiers. Basic service packages might include standard library preparation and sequencing, while premium bundles offer more hands-on support, custom experimental design, or advanced bioinformatics analysis. Researchers can choose the level that best fits their budget and project requirements.
- Bulk Purchasing and Discounts: Core facilities often negotiate bulk discounts with reagent and instrument vendors. Researchers utilizing these facilities benefit indirectly through lower per-sample costs.
- Training and Education Programs: Investing in training programs offered by core facilities empowers researchers to perform certain tasks themselves, reducing reliance on expensive staff time and potentially lowering overall project costs for routine procedures.
- Equipment Sharing Agreements: For institutions with existing but underutilized equipment, formal or informal sharing agreements with neighboring institutions or research groups can maximize asset utilization and reduce the need for new purchases.
- Grant-Supported Core Access: Many funding agencies recognize the importance of core facilities and offer grants or stipends to support access for researchers, particularly for early-career scientists or pilot projects.
- Open-Source Software and Cloud Computing: Utilizing open-source bioinformatics tools and affordable cloud computing platforms for data storage and analysis can significantly reduce expenses compared to proprietary software licenses and on-premises server infrastructure.
- Early-Stage Project Consultation: Engaging with core facility staff for consultation at the project's inception can prevent costly experimental design flaws and ensure efficient use of resources, leading to more successful and cost-effective outcomes.
Verified Providers In Guinea-bissau
In Guinea-Bissau's evolving healthcare landscape, identifying trusted and capable providers is paramount. Franance Health has emerged as a leading force, distinguished by its rigorous credentialing process and unwavering commitment to quality. This document outlines why Franance Health credentials represent the gold standard for healthcare services in the nation, ensuring patients receive the best possible care.
| Provider Type | Franance Health Verification Criteria | Benefits for Patients |
|---|---|---|
| Doctors | Valid medical license, board certification (where applicable), proof of continuous medical education, clean professional record. | Access to highly skilled and experienced physicians, assurance of ethical practice, specialized treatment options. |
| Nurses | Registered nurse license, specialized certifications (e.g., midwifery, critical care), evidence of ongoing training. | Competent and compassionate nursing care, specialized support for various conditions, improved patient recovery. |
| Hospitals and Clinics | Accreditation from relevant health authorities, adherence to safety and hygiene standards, availability of essential equipment and facilities, robust emergency protocols. | Safe and well-equipped healthcare environments, access to comprehensive diagnostic and treatment services, reliable emergency care. |
| Laboratories | Proper licensing, quality control certifications (e.g., ISO), use of validated testing methodologies, accurate and timely results. | Reliable diagnostic testing, precise medical information for treatment decisions, reduced risk of misdiagnosis. |
Key Indicators of Franance Health's Excellence:
- Comprehensive Medical Expertise: Franance Health vets providers for a broad spectrum of medical specialties, ensuring access to qualified professionals for diverse health needs.
- Strict Licensing and Accreditation: All affiliated healthcare facilities and practitioners undergo thorough verification of their official licenses and accreditations from recognized national and international bodies.
- Commitment to Continuous Professional Development: Franance Health prioritizes providers who actively engage in ongoing training and education to stay abreast of the latest medical advancements and best practices.
- Patient-Centered Care Philosophy: Providers are assessed not only on their technical skills but also on their dedication to compassionate, respectful, and patient-focused service delivery.
- Robust Quality Assurance Protocols: Franance Health implements stringent quality control measures to monitor service delivery, patient outcomes, and adherence to established medical standards.
Scope Of Work For Genomics Core Facilities
This document outlines the Scope of Work (SoW) for Genomics Core Facilities, detailing the technical deliverables and standard specifications. The SoW aims to provide a clear understanding of the services offered, expected outputs, and quality standards for genomic services. This ensures efficient operation, reproducible results, and satisfaction of research needs.
| Service | Technical Deliverable | Standard Specification | Quality Control Metrics | Turnaround Time (TAT) | Data Format |
|---|---|---|---|---|---|
| DNA/RNA Extraction | Extracted DNA/RNA sample, QC report | Minimum yield: 100ng (DNA), 50ng (RNA); Purity: A260/A280 ratio 1.8-2.0; Purity: A260/A230 ratio > 1.8; Integrity: RIN > 7 (RNA) | Spectrophotometry (NanoDrop, Qubit), Gel electrophoresis, Bioanalyzer/TapeStation | 2-5 business days | Text file (e.g., CSV for yields/ratios), PDF (QC report) |
| NGS Library Prep | Library DNA, QC report | Library concentration: 5-20 nM; Insert size distribution: Specified range (e.g., 200-600 bp); Library complexity: Assessed by qPCR or unique molecular identifier (UMI) counts | Qubit, Bioanalyzer/TapeStation, qPCR | 5-10 business days | Text file (concentration, insert size), PDF (QC report) |
| NGS Sequencing (e.g., Illumina) | Raw sequencing reads (FASTQ format), QC report | Minimum coverage: Specified per application (e.g., 30x for exome, 100M reads for RNA-Seq); Read quality: Phred score > Q30 for >80% bases; Adapter contamination: <1%; GC content: Within expected range | Sequencer quality metrics (e.g., Illumina's SAV), FastQC, MultiQC | 7-21 business days (post-library loading) | FASTQ (raw reads), BAM/SAM (aligned reads), VCF (variants), BED, BigWig (genome browser tracks) |
| Bioinformatics Analysis | Aligned reads, variant calls, gene expression tables, QC reports, interpretation report | Alignment rate: >90%; Variant calling sensitivity/specificity: Evaluated against known benchmarks; Differential expression: Statistically significant p-values (<0.05); Annotation: Up-to-date databases | Alignment statistics, variant QC, differential expression QC, pathway analysis tools | Variable (dependent on project complexity, typically 10-30 business days) | BAM/SAM, VCF, TSV/CSV (expression tables), HTML/PDF (reports), GFF/GTF (annotations) |
| Single-Cell RNA-Seq | Cell barcodes, UMI counts, QC metrics, annotated cell clusters | Minimum viable cells: Specified (e.g., >1000); Gene detection per cell: Specified average; Cluster purity: >80% for identified cell types | Cell Ranger/10x Genomics analysis pipeline metrics, Seurat/Scanpy QC, UMAP/t-SNE visualization | 14-28 business days (post-library prep) | H5 files, CSV (cell metadata, gene expression), PNG/PDF (visualization plots) |
Key Genomics Services Offered
- DNA/RNA Extraction and Quantification
- Library Preparation for Next-Generation Sequencing (NGS)
- Sequencing Services (e.g., Whole Genome, Exome, RNA-Seq, ChIP-Seq, Single-Cell RNA-Seq)
- Genotyping and SNP Analysis
- Bioinformatics Analysis and Data Interpretation
- Long-Read Sequencing Services (e.g., PacBio, Oxford Nanopore)
- Epigenomic Profiling (e.g., ATAC-Seq, Bisulfite Sequencing)
Service Level Agreement For Genomics Core Facilities
This Service Level Agreement (SLA) outlines the expected response times and uptime guarantees for the Genomics Core Facilities. It defines the standards of service for research projects utilizing our advanced genomic technologies and support.
| Service Category | Response Time Target | Uptime Guarantee | Notes |
|---|---|---|---|
| General Inquiries & Consultations | Within 2 business days | N/A (Support staff availability) | For questions regarding services, experimental design, or protocol optimization. |
| Sample Submission & Onboarding | Within 1 business day of receipt confirmation | N/A (Lab operations) | For acknowledgment and initiation of sample processing. |
| High-Throughput Sequencing Platforms (e.g., Illumina NovaSeq, PacBio Sequel) | N/A (Project-based TAT) | 95% during scheduled operational hours | This covers the availability of the sequencing instruments themselves. TAT for data delivery will be provided at project initiation and can vary based on instrument queue, library complexity, and data analysis requirements. |
| Single-Cell Sequencing Platforms (e.g., 10x Genomics Chromium) | N/A (Project-based TAT) | 95% during scheduled operational hours | This covers the availability of the single-cell instrumentation. TAT for data delivery will be provided at project initiation. |
| Genotyping & SNP Array Services | N/A (Project-based TAT) | 95% during scheduled operational hours | TAT will be communicated at project initiation. |
| Bioinformatics Support & Data Analysis | Initial response within 3 business days, ongoing communication as per project plan | N/A (Consultative service) | Focus is on timely communication and progress updates. Specific analysis TAT is project-dependent. |
| Equipment & Instrument Reservation System | Immediate confirmation or notification of request status | 99% availability of the online booking system | This ensures users can access and manage their instrument bookings. |
Key Performance Indicators (KPIs)
- Response Time: The time elapsed between a user's initial request (e.g., inquiry, sample submission) and acknowledgment/initial action by Core Facility staff.
- Uptime Guarantee: The percentage of scheduled operational time that the Genomics Core Facilities' critical infrastructure and services are available and functional.
- Data Turnaround Time (TAT): The estimated time from sample receipt to data delivery for specific services. This is highly variable and will be communicated on a project-by-project basis.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Genomics Core Facilities in Guinea-Bissau project in Guinea-Bissau.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.